Oberweis Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
GKIM
ACH
HRCM
SIMG
PIM
Oberweis Asset Management's TNDM Position: Q1 2025 in Review
Oberweis Asset Management sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 506,600 shares — an estimated $18.2M sold.
Oberweis Asset Management first reported a position in TNDM in Q3 2018 and held it in 13 quarters. The position peaked at $19M in Q3 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.
- Oberweis Asset Management reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
- Oberweis Asset Management sold 506,600 Tandem Diabetes Care shares in Q1 2025, an estimated $18.2M.
- Oberweis Asset Management first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 13 quarters.
- Oberweis Asset Management's Tandem Diabetes Care position peaked at $19M in Q3 2024.
- 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.
Based on Oberweis Asset Management's 13F filing for Q1 2025, filed 15 May 2025.